NeuroMetrix Reports Quell® Recent Media Coverage

BOSTON--()--NeuroMetrix, Inc. (NASDAQ:NURO) today reported growing media coverage of the Company’s innovative Quell® Wearable Pain Relief Technology™. During the past two months, Quell has been featured on network television affiliates in New York, San Francisco, Philadelphia, Boston, Sacramento and Miami and several significant print and online publications. Highlights include:

“We are pleased with the extent of coverage Quell has attracted in the media. In the past eight weeks Quell was covered on broadcast news in three of the top five TV markets,” said Frank McGillin, Senior VP and General Manager NeuroMetrix Consumer Health. “Quell is making a difference in the lives of the millions Americans suffering from chronic pain, and we look forward to further expanding awareness of our patented technology.”

About Quell Wearable Pain Relief Technology

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's patented technology to provide widespread pain relief. In a recent clinical study, Quell improved chronic pain in 81% of participants. Quell is currently available through select healthcare professionals, retailers and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

$Cashtags

Contacts

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com